TIM SCOTT is an accomplished trekker. He’s conquered Kilimanjaro (19,340 feet), and recently hiked through Nepal to Everest Base Camp (17,500 feet) and Kala Pathar (18,300 feet). Careerwise, you could say he’s been attempting to climb another mountain, that of drug development and manufacturing outsourcing. And he’s doing it from both approaches to the summit.
He cofounded and lead a successful CDMO and is now doing the same at a biotech startup. When I ask him for the fundamental differences between leading organizations on the buy and sell sides of drug development and manufacturing, he starts with the financing of the two business models. “The financial pro forma driving the two businesses are so different,” he says. “It’s no wonder CDMOs and their biotech customers don’t always see eye-to-eye.” Scott is eager to share his experience to help form a mutual vision of what the summit of success looks like for drug sponsor and service provider alike.